Rapt Therapeutics, Inc.盘中异动早盘大幅下挫10.34%报1.56美元

市场透视2024-12-24

北京时间2024年12月24日22时31分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价急速下跌10.34%。截至发稿，该股报1.56美元/股，成交量95.3474万股，换手率2.73%，振幅4.02%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-18.43百万美元，每股收益-0.47美元，毛利-297000.00美元，市盈率-0.56倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2493824900?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-24 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2493824900","market":"us","top_or_hot":-1,"title":"Rapt Therapeutics, Inc.盘中异动 早盘大幅下挫10.34%报1.56美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月24日22时31分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价急速下跌10.34%。截至发稿，该股报1.56美元/股，成交量95.3474万股，换手率2.73%，振幅4.02%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-18.43百万美元，每股收益-0.47美元，毛利-297000.00美元，市盈率-0.56倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223135a207c01f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rapt Therapeutics, Inc.盘中异动 早盘大幅下挫10.34%报1.56美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRapt Therapeutics, Inc.盘中异动 早盘大幅下挫10.34%报1.56美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-24 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223135a207c01f&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月24日22时31分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价急速下跌10.34%。截至发稿，该股报1.56美元/股，成交量95.3474万股，换手率2.73%，振幅4.02%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-18.43百万美元，每股收益-0.47美元，毛利-297000.00美元，市盈率-0.56倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223135a207c01f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223135a207c01f&s=b","article_id":"2493824900","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224223135a207c01f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2493824900","pubTimestamp":1735050694,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月24日22时31分，Rapt Therapeutics, Inc.股票出现波动，股价急速下跌10.34%。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。消息层面，截至22时31分，《济煜医药与RAPT宣布针对新型长效IgE抗体达成独家许可协议》资讯为影响Rapt Therapeutics, Inc.的重要信息。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics","RAPT":"RAPT Therapeutics, Inc."},"translate_title":"Rapt Therapeutics, Inc. fell 10.34% to $1.56 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RAPT":0.9,"LENZ":1},"content_text":"北京时间2024年12月24日22时31分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价急速下跌10.34%。截至发稿，该股报1.56美元/股，成交量95.3474万股，换手率2.73%，振幅4.02%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-18.43百万美元，每股收益-0.47美元，毛利-297000.00美元，市盈率-0.56倍。机构评级方面，在所有5家参与评级的机构中，20%的券商给予买入建议，60%的券商给予持有建议，20%的券商给予卖出建议。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Clearmind Medicine Inc.、180 Life Sciences Corp C/Wts 07/11/2025(To Pur Com)、180 Life Sciences Corp.涨幅较大，Clearmind Medicine Inc.、180 Life Sciences Corp.、Theriva Biologics, Inc.较为活跃，换手率分别为887.90%、558.21%、97.89%，振幅较大的相关个股有Theriva Biologics, Inc.、Clearmind Medicine Inc.、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon，振幅分别为20.76%、12.28%、11.67%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。它专注于发现、开发和商业化口服小分子疗法用于未满足需求的肿瘤和炎症疾病患者。该公司的管道产品包括FLX475，旨在选择性地抑制免疫抑制调节性T细胞向肿瘤的迁移;RPT193，旨在选择性地抑制2型T辅助细胞向炎症组织的迁移。消息层面，截至22时31分，《济煜医药与RAPT宣布针对新型长效IgE抗体达成独家许可协议》资讯为影响Rapt Therapeutics, Inc.的重要信息。该信息摘要如下：上海济煜医药科技有限公司（以下简称“济煜医药”）与RAPT Therapeutics（以下简称“RAPT”）达成一项独家许可协议，济煜医药将具有自主知识产权的新型长效IgE抗体JYB1904在大中华区以外的全球的开发及商业化权利独家许可给RAPT。济煜医药正在中国区进行JYB1904治疗哮喘和CSU的2期临床试验。在2021年-2022年期间，济煜医药先后完成了三个临床前项目的海外授权，本次交易是济煜医药第四个海外授权在研产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493824900","isCrawlerRequest":true}

Rapt Therapeutics, Inc.盘中异动 早盘大幅下挫10.34%报1.56美元

精彩评论

Rapt Therapeutics, Inc.盘中异动早盘大幅下挫10.34%报1.56美元